The Pharma Data

AUGUST 17, 2021

approval of pump use for Lilly’s novel insulin is latest development designed to help people with diabetes manage blood sugar levels. Lyumjev, a novel formulation of insulin lispro developed to speed the absorption of insulin into the bloodstream and reduce A1C levels, was approved by the FDA in June 2020.

Insulin 52

Insulin FDA Approval Doctor Doctors 52

Scienmag

OCTOBER 29, 2020

USF Health-led TEDDY analysis focuses on development of multiple distinct autoantibodies targeting insulin-producing cells, from initial autoimmunity to symptomatic type 1 diabetes Credit: Courtesy of USF Health TAMPA, Fla.

Genetics 92

Genetics Insulin Development Clinical Trials 92

The Pharma Data

DECEMBER 17, 2020

7, 2020 — After starting a drug that’s officially approved to treat a type of blood cancer, a young man with type 1 diabetes was able to stop using insulin. He’s been off insulin since August 2018 — more than two years. WEDNESDAY, Oct. No treatments are approved for reversing type 1 diabetes.

Insulin 52

Insulin Genetics Doctor Doctors 52

The Pharma Data

DECEMBER 30, 2020

Your likelihood of putting on weight also comes down to your microbiome and the influence it has on your response to insulin and thyroid gland function. Luckily, even a lifetime of bad eating habits is fixable.

Bacteria 52

Bacteria Insulin Allergies Doctor 52

Trialfacts

OCTOBER 10, 2022

Must not have type 1 diabetes or be taking insulin. Must not have an allergy to perflutren. Must have a BMI of >28 and <45 kg/m². Must not perform more than 30 minutes of moderate to high-intensity exercise for more than twice per week. Must not currently take any active weight suppression medication.

Research 52

Research Insulin Allergies Development 52

Trialfacts

MARCH 18, 2024

Men and women aged 18 and above who are diagnosed with type 2 diabetes Must have obesity or be overweight, with a BMI of 27 or higher Must be willing and able to use effective contraception Must not be pregnant or planning to be pregnant within the following year Can be on CPAP therapy for sleep apnea or untreated Must not have had a prior or planned (..)

Insulin 52

Insulin Research Allergies Production 52

Trialfacts

DECEMBER 13, 2023

Men and women aged 18 and above who are diagnosed with type 2 diabetes Must have obesity or be overweight, with a BMI of 27 or higher Must be willing and able to use effective contraception Must not be pregnant or planning to be pregnant within the following year Can be on CPAP therapy for sleep apnea or untreated Must not have had a prior or planned (..)

Insulin 52

Insulin Research Allergies Production 52